Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-25-000148
Filing Date
2025-11-06
Accepted
2025-11-06 16:30:03
Documents
90
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfcr-20250930.htm   iXBRL 10-Q 910085
2 EX-10.1 lfcr-20250930xexx101consen.htm EX-10.1 69334
3 EX-10.2 lfcr-20250930xexx102consen.htm EX-10.2 63628
4 EX-31.1 lfcr-20250930xexx311.htm EX-31.1 10848
5 EX-31.2 lfcr-20250930xexx312.htm EX-31.2 10443
6 EX-32.1 lfcr-20250930xexx321.htm EX-32.1 5638
7 EX-32.2 lfcr-20250930xexx322.htm EX-32.2 5515
  Complete submission text file 0001005286-25-000148.txt   7463423

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20250930.xsd EX-101.SCH 54250
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfcr-20250930_cal.xml EX-101.CAL 80980
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfcr-20250930_def.xml EX-101.DEF 313866
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20250930_lab.xml EX-101.LAB 780100
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20250930_pre.xml EX-101.PRE 549828
93 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20250930_htm.xml XML 894905
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 251458913
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)